SecBot SecBot
425 ·Filed Sep 14, 2026

MMED

MiniMed Group, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed2mo ago SEC0001628280-26-061699
Actionable Insight • Neutral

This filing is procedural and contains no new financial information or changes to deal terms. Monitor the exchange offer expiration and subsequent trading volume for MMED as Medtronic's stake is distributed to a broader shareholder base, which could increase free float and liquidity. The key catalyst remains the completion of the separation and MiniMed's standalone operating results.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$21.97
T+0 close · Sep 14, 2026 · via day close
Latest settled
−14.43%
T+20 · $18.80 · next T+60 in 21d
Vs SPY
−16.69%
α at T+20
Latest observation
−15.11%
T+44 · FF3 residual α
  1. T+0 · Sep 14 $21.97entry
  2. T+1 · 2mo ago +0.18%α +0.64% · $22.01
  3. T+5 · 8w ago −3.87%α −3.98% · $21.12
  4. T+20 · 5w ago −14.43%α −16.69% · $18.80
  5. T+45 · todayOpen
  6. T+60 · in 21d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

MiniMed filed a 425 communication providing employees with procedural details about Medtronic's exchange offer to divest its remaining ~89.86% stake in MiniMed. This is a routine informational filing for employee participation in the exchange offer, confirming the separation timeline is on track with no changes to deal terms or new financial projections. The filing is a procedural step in the final stage of MiniMed becoming a fully independent company.

Key Facts

  • Medtronic currently owns approximately 89.86% of MiniMed's outstanding common stock.
  • Medtronic has commenced an exchange offer for its shareholders to swap Medtronic ordinary shares for newly issued MiniMed common stock.
  • Upon completion of the exchange offer, Medtronic will no longer hold an equity stake in MiniMed.
  • The filing provides employee-specific instructions for tendering shares, including details on vested Medtronic equity awards and ESPP shares.
  • MiniMed completed its IPO on March 9, 2026, and the separation was initially announced on May 21, 2025.

Financial Impact

No new financial data or deal value disclosed in this filing. The exchange offer involves Medtronic's remaining ~89.86% stake in MiniMed, valued at approximately $5.66B based on a $6.3B market cap.

ownership_structuredilution

Risk Factors

  • Exchange offer may not be fully subscribed, leaving Medtronic with a residual stake.
  • Post-separation execution risk as MiniMed operates independently without Medtronic support.
  • Potential tax implications for Medtronic shareholders participating in the exchange could affect participation rates.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
89% bullish (18 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
425 Filing (MMED), Batch item 10001628280-26-061699
Document: 0001628280-26-061699-index-headers.html0001628280-26-061699
Document: 0001628280-26-061699-index.html0001628280-26-061699
Document: 0001628280-26-061699.txt0001628280-26-061699
425 Filing (MMED), Batch item 50001628280-26-061699
Document: 0001628280-26-061699-index-headers.html0001628280-26-061699
Document: 0001628280-26-061699-index.html0001628280-26-061699
Document: 0001628280-26-061699.txt0001628280-26-061699

Track record

25 reports on MMED

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 16, 2026today 8-K Mixed 6/10 Entry $18.77 Now $18.65 −0.64% settles Dec 15
  2. Nov 16, 2026today Press Release Bullish 7/10 Entry $18.81 Now $18.65 −0.86% settles Dec 15
  3. Nov 6, 202610d ago SC 13G Neutral 4/10 Entry $16.71 Now $18.65 +11.61% settles Dec 7
  4. Oct 22, 202625d ago SC 13G Neutral 4/10 Entry $18.34 Now $18.65 +1.69% settles Nov 20
  5. Oct 16, 20264w ago SC 13G/A Neutral 4/10 Entry $17.79 to $18.65 Now $18.65 +4.83% ▲ +4.83% +8.30% vs SPY
  6. Oct 16, 20264w ago 8-K Neutral 6/10 Entry $17.49 to $17.99 Now $18.65 +6.63% ▲ +2.86% +4.02% vs SPY
  7. Oct 6, 20265w ago EFFECT Neutral 3/10 Entry $19.64 to $18.85 Now $18.65 −5.04% ▼ −4.02% −0.85% vs SPY
  8. Oct 1, 20266w ago 3 Neutral 2/10 Entry $19.70 to $18.28 Now $18.65 −5.33% ▼ −7.21% −5.40% vs SPY
  9. Sep 14, 20269w ago 425 Neutral 4/10 Entry $21.97 to $18.80 Now $18.65 −15.11% ▼ −14.43% −16.69% vs SPY
  10. Sep 14, 20269w ago 425 Neutral 4/10 Entry $21.97 to $18.80 Now $18.65 −15.11% ▼ −14.43% −16.69% vs SPY
Showing 10 of 25

US Market Status

Market Closed · Opens Wed (11h 7m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 14, 2026